Partners
Trakia Hospital
Trakia Hospital is one of the largest and most modern hospitals in Bulgaria, equipped with last generation high-tech equipment. In the health facility there work highly qualified specialists in surgery, cardiology, gynaecology, urology, neurology, orthopaedics, physiotherapy, gastroenterology, eye and ENT diseases, children's diseases, imaging and others.
Trakia Hospital is situated in two buildings. The first hospital was officially opened in February 2009. The building is located in the central part of Stara Zagora. The second hospital building was opened in April 2014 and is positioned near the covered with pine forests Ayazmoto Park and overlooking the city stadium of Beroe.
http://trakiahospital.com/en/home/
Novo Nordisk
Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. This heritage has given them experience and capabilities that also enable them to help people defeat other serious chronic conditions: haemophilia, growth disorders and obesity.
Headquartered in Denmark, Novo Nordisk employs approximately 42,300 people in 75 countries and markets its products in more than 180 countries.
www.novonordisk.com
Walmark
Walmark is a company with Czech origin established in 1990. Thanks to the respect, loyalty and popularity among its customers in the past 25 years, Walmark has turned into one of the biggest producers of food supplements among countries in CEE. The company is present in 9 countries in Europe and has successful export business in more than 50 countries, including Saudi Arabia, Iran and others.
Walmark is а leader on the Food supplements market in Bulgaria. From the opening of the branch till today, the company is number one player, offering food supplements in more than 20 product categories. The most popular brands are Urinal – for urinary tract infections, Proenzi – complete joints care, Martians – loved kids multivitamins, GinkoPrim – for better memory and circulation. The mission of the company is to ensure innovative, high quality products and services in the field of health care, to stimulate active and heathy lifestyle among consumers, to inspire them to take a step towards better health.
www.walmark.eu
Roche
Roche was one of the first companies to bring targeted treatments to patients. With their combined strength in pharmaceuticals and diagnostics, they are better equipped than any other company to further drive personalised healthcare. Two-thirds of our Research and Development projects are being developed with companion diagnostics.
F. Hoffmann-La Roche & Co. was founded at a time when industrial revolution was changing the face of Europe. On October 1, 1896, at the age of 28, Fritz Hoffmann-La Roche launched his company as the successor company to Hoffmann, Traub & Co in Basel, Switzerland. He was among the first to recognise that the industrial manufacture of medicines would be a major advance in the fight against disease. Since then, Roche has grown into one of the world's leading healthcare companies.
www.roche.com
AstraZeneca
AstraZeneca is a global, science-led biopharmaceutical company that spans the discovery, development, manufacturing, distribution and worldwide commercialisation of primary care and speciality care medicines. We believe the best way we can help patients is to focus on breakthrough science in order to uncover disease mechanisms and develop novel, targeted therapies that interact with them. This is at the heart of our purpose as a company: to push the boundaries of science to deliver life-changing medicines. We invest in distinctive science in three main therapy areas where we believe we can make the most meaningful difference to patients: oncology; cardiovascular and metabolic diseases; and respiratory, inflammation and autoimmunity. Our science exploits our rare combination of capabilities in small molecules and biologics, immunotherapies, protein engineering technologies and devices. These are reinforced by a strong focus on translational science and personalised healthcare capabilities. We build on our own capabilities by collaborating with world-renowned scientists and academic institutions and partnering with like-minded science-led companies. Through leading in science, we are confident that we can transform the lives of people around the world and deliver value to our shareholders.
www.astrazeneca.com